Medical devices

Information session on the pilot for expert panels' advice for orphan medical devices, Online, European Medicines Agency, Amsterdam, the Netherlands, from 23 September 2024, 14:00 (CEST) to 23 September 2024, 16:00 (CEST)

European Shortages Monitoring Platform Essentials and Industry Reporting Requirements, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 24 June 2024, 10:00 (CEST) to 24 June 2024, 12:30 (CEST)

Human medicines European public assessment report (EPAR): Remsima, infliximab, Date of authorisation: 10/09/2013, Revision: 41, Status: Authorised

Policy 82: Union Product Database (UPD) Access Policy - Veterinary Medicinal Products

Human medicines European public assessment report (EPAR): Tecentriq, atezolizumab, Date of authorisation: 20/09/2017, Revision: 28, Status: Authorised

Human medicines European public assessment report (EPAR): Keytruda, pembrolizumab, Date of authorisation: 17/07/2015, Revision: 59, Status: Authorised

PRIME: priority medicines

List of medicines currently in PRIME scheme

Recommendations on eligibility to PRIME scheme - Adopted at the CHMP meeting of 22-25 July 2024